Skip to main content
. Author manuscript; available in PMC: 2019 Dec 14.
Published in final edited form as: ACS Infect Dis. 2019 Mar 28;5(6):974–981. doi: 10.1021/acsinfecdis.9b00039

Table 1.

Serum IgG Subclass Anti-rHagB Activity at Week 6a

entry adjuvant IgG1 (μg/mL) IgG2a (μg/mL) IgG2a/IgG1
1 none 1090 ± 140 16 ± 5 0.014 ± 0.003
2 GPI-0100 1221 ± 80 231 ± 33 0.192 ± 0.031**
3 5 1605 ± 142 238 ± 86 0.142 ± 0.048*
4 6 1219 ± 147 11 ± 2 0.010 ± 0.001
a

Values are expressed as mean ± SEM.

Statistical significance compared with no-adjuvant control group:

*

P < 0.05,

**

P < 0.01, and

***

P < 0.001.